Table 1.
• Defining role of parasitic genotypic variation in the variability of disease prevalence and severity |
• Better treatment options for prevention of transmission of Toxoplasma infection from a pregnant woman to her fetus |
• Better drugs for treatment of infants and children with congenital toxoplasmosis |
• Effective approaches for toxoplasmosis screening in pregnant women |
• Strategies to improve food safety |